These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9458276)

  • 1. Chronic exogenous insulin and chronic carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats.
    Park J; Lemieux S; Lewis GF; Kuksis A; Steiner G
    J Lipid Res; 1997 Dec; 38(12):2529-36. PubMed ID: 9458276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial.
    Geidl-Flueck B; Hochuli M; Németh Á; Eberl A; Derron N; Köfeler HC; Tappy L; Berneis K; Spinas GA; Gerber PA
    J Hepatol; 2021 Jul; 75(1):46-54. PubMed ID: 33684506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model.
    Taghibiglou C; Carpentier A; Van Iderstine SC; Chen B; Rudy D; Aiton A; Lewis GF; Adeli K
    J Biol Chem; 2000 Mar; 275(12):8416-25. PubMed ID: 10722675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of de novo fatty acid synthesis to very low density lipoprotein triacylglycerols: evidence from mass isotopomer distribution analysis of fatty acids synthesized from [2H6]ethanol.
    Yang LY; Kuksis A; Myher JJ; Steiner G
    J Lipid Res; 1996 Feb; 37(2):262-74. PubMed ID: 9026525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of exogenous free fatty acids for the production of very low density lipoprotein triglyceride by livers of carbohydrate-fed rats.
    Schonfeld G; Pfleger B
    J Lipid Res; 1971 Sep; 12(5):614-21. PubMed ID: 5098397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired very low-density lipoprotein-triglyceride catabolism in acute and chronic fructose-fed rats.
    Hirano T; Mamo JC; Poapst ME; Kuksis A; Steiner G
    Am J Physiol; 1989 Apr; 256(4 Pt 1):E559-65. PubMed ID: 2705524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in very low density lipoprotein particle size and production in response to sucrose feeding and hyperinsulinemia.
    Kazumi T; Vranic M; Steiner G
    Endocrinology; 1985 Sep; 117(3):1145-50. PubMed ID: 4017959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mild diabetes and dietary fructose on very-low-density lipoprotein triglyceride turnover in rats.
    Yoshino G; Matsushita M; Iwai M; Morita M; Matsuba K; Nagata K; Maeda E; Furukawa S; Hirano T; Kazumi T
    Metabolism; 1992 Mar; 41(3):236-40. PubMed ID: 1542260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic exogenous hyperinsulinaemia does not modify the acute inhibitory effect of insulin on the secretion of very-low-density lipoprotein triacylglycerol and apolipoprotein B in primary cultures of rat hepatocytes.
    Bourgeois CS; Wiggins D; Gibbons GF
    Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):103-8. PubMed ID: 8660269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men.
    Aarsland A; Wolfe RR
    J Lipid Res; 1998 Jun; 39(6):1280-6. PubMed ID: 9643360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals.
    Lewis GF; Uffelman KD; Szeto LW; Steiner G
    Diabetes; 1993 Jun; 42(6):833-42. PubMed ID: 8495807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.
    Elam MB; von Wronski MA; Cagen L; Thorngate F; Kumar P; Heimberg M; Wilcox HG
    Lipids; 1999 Aug; 34(8):809-16. PubMed ID: 10529091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
    Kazumi T; Hirano T; Odaka H; Ebara T; Amano N; Hozumi T; Ishida Y; Yoshino G
    Diabetes; 1996 Jun; 45(6):806-11. PubMed ID: 8635657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin therapy in burn patients does not contribute to hepatic triglyceride production.
    Aarsland A; Chinkes DL; Sakurai Y; Nguyen TT; Herndon DN; Wolfe RR
    J Clin Invest; 1998 May; 101(10):2233-9. PubMed ID: 9593779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians.
    Abbott WG; Swinburn B; Ruotolo G; Hara H; Patti L; Harper I; Grundy SM; Howard BV
    J Clin Invest; 1990 Aug; 86(2):642-50. PubMed ID: 2200808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man.
    Aarsland A; Chinkes D; Wolfe RR
    J Clin Invest; 1996 Nov; 98(9):2008-17. PubMed ID: 8903319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Fructose Feeding on Intestinal Triacylglycerol Production and De Novo Fatty Acid Synthesis in Humans.
    Steenson S; Shojaee-Moradie F; B Whyte M; G Jackson K; Lovegrove JA; A Fielding B; Umpleby AM
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32549314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of Troglitazone in patients with diet-controlled type 2 diabetes.
    Robinson AC; Jeffs JA; Gray RG; Bannister PA; Mather H; Gallagher JJ; Robinson S; Nattrass M; Venkatesan S; Halliday D; Johnston DG
    Eur J Clin Invest; 2004 Jan; 34(1):29-36. PubMed ID: 14984435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.